Cargando…

Chronic kidney disease and risks of adverse clinical events in patients with atrial fibrillation

BACKGROUND: Chronic kidney disease (CKD) is highly prevalent in patients with atrial fibrillation (AF). However, the association between CKD and clinical consequences in AF patients is still under debate. METHODS: We included 19,079 nonvalvular AF patients with available estimated glomerular filtrat...

Descripción completa

Detalles Bibliográficos
Autores principales:	LI, Si-Tong, JIANG, Chao, HE, Liu, LI, Qi-Fan, DING, Zuohan, WU, Jia-Hui, HU, Rong, LV, Qiang, LI, Xu, JIA, Chang-Qi, RUAN, Yan-Fei, NING, Man, FENG, Li, BAI, Rong, TANG, Ri-Bo, DU, Xin, DONG, Jian-Zeng, MA, Chang-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648544/ https://www.ncbi.nlm.nih.gov/pubmed/34908924 http://dx.doi.org/10.11909/j.issn.1671-5411.2021.11.002

Ejemplares similares

Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events
por: Li, Chen-Yu, et al.
Publicado: (2015)

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
por: Zhang, Zhuxin, et al.
Publicado: (2021)

Plasma Asymmetric Dimethylarginine and Adverse Events in Patients with Atrial Fibrillation Referred for Coronary Angiogram
por: Chao, Tze-Fan, et al.
Publicado: (2013)

Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study
por: Li, Zhi-Zhao, et al.
Publicado: (2022)

Mitral annular calcification is associated with atrial fibrillation and major cardiac adverse events in atrial fibrillation patients: A systematic review and meta-analysis
por: Li, Yimin, et al.
Publicado: (2019)

The Association of New-Onset Atrial Fibrillation and Risk of Cancer: A Systematic Review and Meta-Analysis
por: Zhang, Mengxia, et al.
Publicado: (2020)

Atrial fibrosis underlying atrial fibrillation (Review)
por: Li, Chang Yi, et al.
Publicado: (2021)

Comparison of prognosis and outcomes of catheter ablation versus drug therapy in patients with atrial fibrillation and stable coronary artery disease: A prospective propensity‐score matched cohort study
por: Cui, Yi‐Kai, et al.
Publicado: (2021)

Association Between Blood Lipid Profiles and Atrial Fibrillation: A Case-Control Study
por: Li, Zhi-Zhao, et al.
Publicado: (2018)

Atrial fibrillation and frailty
por: Guo, Qi, et al.
Publicado: (2020)

Clustering of Unhealthy Lifestyle and the Risk of Adverse Events in Patients With Atrial Fibrillation
por: Lee, So-Ryoung, et al.
Publicado: (2022)

microRNAs as biomarkers of risk of major adverse cardiovascular events in atrial fibrillation
por: de los Reyes-García, Ascensión M., et al.
Publicado: (2023)

Biatrial Macroreentry Atrial Tachycardia after Atrial Fibrillation Ablation
por: Huang, Shen, et al.
Publicado: (2016)

Circulating Magnesium and Risk of Major Adverse Cardiac Events among Patients with Atrial Fibrillation in the ARIC Cohort
por: Li, Linzi, et al.
Publicado: (2023)

Risk of New-Onset Atrial Fibrillation Post-cavotricuspid Isthmus Ablation in Typical Atrial Flutter Without History of Atrial Fibrillation
por: Li, Jia-hui, et al.
Publicado: (2021)

Digoxin Use and Adverse Outcomes in Patients With Atrial Fibrillation
por: Zeng, Wu-Tao, et al.
Publicado: (2016)

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants
por: Chan, Yi-Hsin, et al.
Publicado: (2020)

Visualization and mapping of the right phrenic nerve by intracardiac echocardiography during atrial fibrillation ablation
por: Liu, Xinmeng, et al.
Publicado: (2023)

Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
por: Gao, Ming‐Yang, et al.
Publicado: (2023)

Association Between Rs3807989 Polymorphism in Caveolin-1 (CAV1) Gene and Atrial Fibrillation: A Meta-Analysis
por: Jia, Wenjun, et al.
Publicado: (2016)

Residual flow may increase the risk of adverse events in patients received combined catheter ablation and transcatheter left atrial appendage closure for nonvalvular atrial fibrillation: a meta-analysis
por: Han, Zhonglin, et al.
Publicado: (2019)

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials
por: Brown, Jennifer R., et al.
Publicado: (2017)

Four‐year incidence of major adverse cardiovascular events in patients with atherosclerosis and atrial fibrillation
por: Miao, Benjamin, et al.
Publicado: (2020)

ATRIAL FIBRILLATION AND MAJOR ADVERSE CARDIOVASCULAR EVENTS AMONG HOSPITALIZED COVID-19 PATIENTS
por: Aten, Kristopher, et al.
Publicado: (2022)

Impact of atrial fibrillation on the risk of major adverse cardiac events following coronary revascularisation
por: Jung, Richard G, et al.
Publicado: (2022)

Atrial fibrillation is a risk factor for major adverse cardiovascular events in COVID-19
por: Cutler, Michael J., et al.
Publicado: (2022)

Mortality and Major Adverse Cardiovascular Events in Hospitalized Patients With Atrial Fibrillation With COVID-19
por: Wang, Lucas, et al.
Publicado: (2023)

Prognostic Significance of Left Ventricular Fibrosis Assessed by T1 Mapping in Patients with Atrial Fibrillation and Heart Failure
por: Zhao, Lei, et al.
Publicado: (2019)

Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
por: Dong, Zhaojie, et al.
Publicado: (2021)

Early Coagulation Disorder Is Associated With an Increased Risk of Atrial Fibrillation in Septic Patients
por: Long, Yunxiang, et al.
Publicado: (2021)

Sodium-Glucose Cotransporter 2 Inhibitors Potentially Prevent Atrial Fibrillation by Ameliorating Ion Handling and Mitochondrial Dysfunction
por: Peng, Xiaodong, et al.
Publicado: (2020)

Relation of Body Mass Index With Adverse Outcomes Among Patients With Atrial Fibrillation: A Meta‐Analysis and Systematic Review
por: Zhu, Wengen, et al.
Publicado: (2016)

Retrospective Study of 1255 Non-Anticoagulated Patients with Nonvalvular Atrial Fibrillation to Determine the Risk of Ischemic Stroke Associated with Left Atrial Spontaneous Echo Contrast on Transesophageal Echocardiography
por: Liu, Kesen, et al.
Publicado: (2021)

Female Sex as a Risk Factor for Ischemic Stroke and Systemic Embolism in Chinese Patients With Atrial Fibrillation: A Report From the China‐AF Study
por: Lan, Di‐Hui, et al.
Publicado: (2018)

Case report: Catheter ablation for persistent atrial fibrillation in a patient with heart of stone
por: Deng, Yingjian, et al.
Publicado: (2023)

Effects of Left Atrial Appendage Closure on Neuroendocrine Function in Patients with Nonvalvular Atrial Fibrillation
por: Wang, Fei, et al.
Publicado: (2022)

Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function
por: Pham, Phuong, et al.
Publicado: (2020)

Nano drugs delivery system: A novel promise for the treatment of atrial fibrillation
por: Wang, Zhengjie, et al.
Publicado: (2022)

SGLT-2 inhibitors and atrial fibrillation in the Food and Drug Administration adverse event reporting system
por: Bonora, Benedetta Maria, et al.
Publicado: (2021)

Atrial fibrillation after vaccination for COVID-19: analysis of the vaccine adverse event reporting system
por: Kumar, Ashish, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_66mlm8nbb2iqjbhp13j48oaddt